These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2312 related items for PubMed ID: 2832438

  • 21. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 24. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE, Schoenfeld DA, Martin KA, Crowley WF.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [Abstract] [Full Text] [Related]

  • 25. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 26. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct 01; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 27. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T.
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep 20; 52(9):881-97. PubMed ID: 828583
    [Abstract] [Full Text] [Related]

  • 28. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.
    Suganuma C, Kuroiwa T, Tanaka T, Kamomae H.
    Anim Reprod Sci; 2007 Oct 20; 101(3-4):285-94. PubMed ID: 17027203
    [Abstract] [Full Text] [Related]

  • 29. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM, Nestor JJ, Vickery BH.
    Endocrinology; 1987 Aug 20; 121(2):612-8. PubMed ID: 3109885
    [Abstract] [Full Text] [Related]

  • 30. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 31. The use of anti-progesterones as a medical IUD.
    Nieman LK, Loriaux DL.
    Baillieres Clin Obstet Gynaecol; 1988 Sep 15; 2(3):609-16. PubMed ID: 3233821
    [Abstract] [Full Text] [Related]

  • 32.
    Holesh JE, Bass AN, Lord M.
    ; 2024 01 15. PubMed ID: 28723025
    [Abstract] [Full Text] [Related]

  • 33. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S, Charbonnel B, Massai MR, Marraoui J, Spitz I, Bouchard P.
    Fertil Steril; 1991 Sep 15; 56(3):440-5. PubMed ID: 1894021
    [Abstract] [Full Text] [Related]

  • 34. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH.
    J Endocrinol; 1975 Jan 15; 64(1):37-47. PubMed ID: 1167896
    [Abstract] [Full Text] [Related]

  • 35. Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum.
    Caruso A, Lanzone A, Fulghesu AM, Mancuso S.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):274-8. PubMed ID: 3098770
    [Abstract] [Full Text] [Related]

  • 36. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB, Reame NE, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1989 Jul 15; 69(1):67-76. PubMed ID: 2499593
    [Abstract] [Full Text] [Related]

  • 37. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
    Sánchez-Criado JE, Galiot F, Bellido C, Gonzalez D, Tébar M.
    Biol Reprod; 1993 Apr 15; 48(4):916-25. PubMed ID: 8485257
    [Abstract] [Full Text] [Related]

  • 38. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL, Hodgen GD, Ottobre AC, Christian CD.
    J Clin Endocrinol Metab; 1984 Jun 15; 58(6):1027-33. PubMed ID: 6427256
    [Abstract] [Full Text] [Related]

  • 39. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.
    Stuenkel CA, Garzo VG, Morris S, Liu JH, Yen SS.
    Fertil Steril; 1990 Apr 15; 53(4):642-6. PubMed ID: 2156736
    [Abstract] [Full Text] [Related]

  • 40. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ, Bangah ML, Kettel LM, Vale W, Rivier J, Burger HG, Yen SS.
    J Clin Endocrinol Metab; 1989 Nov 15; 69(5):1033-9. PubMed ID: 2507568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 116.